Neuroinflammation

Neuroinflammation plays a crucial role in the progression of Alzheimer’s disease and dementia. In these conditions, the brain's immune response becomes dysregulated, leading to chronic inflammation that exacerbates neuronal damage. Microglia, the resident immune cells in the brain, play a dual role: they can either protect neurons by clearing debris or exacerbate damage by releasing inflammatory molecules.

In Alzheimer’s, beta-amyloid plaques and tau tangles trigger microglial activation, which in turn releases pro-inflammatory cytokines, further damaging neurons. This chronic inflammation contributes to cognitive decline and neurodegeneration characteristic of these diseases. Understanding and managing neuroinflammation is pivotal in developing effective treatments for Alzheimer’s and dementia. Targeting immune-modulating therapies or interventions that regulate microglial activation could potentially slow disease progression and improve quality of life for patients.